Healthy Prenatal Diet Tied to Healthier Infant Growth Patterns
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Adhering to a healthy prenatal diet may reduce patterns of infant growth outside reference ranges, according to a study published online Nov. 21 in JAMA Network Open.
Monique M. Hedderson, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues evaluated the relationship between prenatal dietary quality according to the Healthy Eating Index (HEI) and the Empirical Dietary Inflammatory Pattern (EDIP) with infant size at birth and infant growth from birth to age 24 months. The analysis included data from 2,854 birthing parent–child dyads participating in the Environmental influences on Child Health Outcomes program between 2007 and 2021.
The researchers found that a high HEI score (>80), indicative of a healthier diet, was associated with lower odds of large for gestational age (adjusted odds ratio [aOR], 0.88); rapid growth from birth to age 6 months (aOR, 0.80) and age 24 months (aOR, 0.82); and slow growth from birth to age 6 months (aOR, 0.65), 12 months (aOR, 0.74), and 24 months (OR, 0.65) compared with an HEI score ≤80. A low EDIP score (i.e., ≤63.6), indicative of a less inflammatory diet, was associated with higher odds of large for gestational age and rapid infant growth from birth to age 12 months and lower odds of rapid growth to age 6 months. Small for gestational age was not associated with either HEI or EDIP.
"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges, which are risk factors associated with obesity," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-28 06:00
Read more
- Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
- ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
- 2021 to 2022 Saw Decline in Abortions in the United States
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
- Healthy Eating Index 2015 Score Linked to Overactive Bladder
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions